Ozanimod Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Ozanimod Hydrochloride
Health Canada Patents

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Ozanimod Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

20 API Suppliers, 6 USDMF, 1 EU WC, 8 NDC API, 10 Listed Suppliers, $ API Reference Price

20 API Suppliers
6 USDMF
1 EU WC
8 NDC API
10 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

65 Drugs in Development

65 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

15 FDF Dossiers, 5 FDA Orange Book, 2 Europe, 5 Australia, 3 Listed Dossiers

15 FDF Dossiers
5 FDA Orange Book
2 Europe
5 Australia
3 Listed Dossiers

DIGITAL CONTENT

1 Stock Recap #PipelineProspector, 64 News #PharmaBuzz

1 Stock Recap #PipelineProspector
64 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Regulatory FDF Prices, 5 Annual Reports

1 US Medicaid Prescriptions
2 Regulatory FDF Prices
5 Annual Reports

MARKET PLACE

6 APIs

6 APIs

PATENTS & EXCLUSIVITIES

18 US Patents, 6 US Exclusivities, 6 Health Canada Patents

18 US Patents
6 US Exclusivities
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ API Ref.Price (USD/KG) : 257,511 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6McCarthy Tétrault

filter Patent Reset all filters

6 All

01 32723904

02 32780772

filter Product Reset all filters

6 All

01 6OZANIMOD HYDROCHLORIDE

filter Dosage Reset all filters

6 All

01 4CAPSULE

02 2KIT

filter Exp Date Reset all filters

6 All

01 32029-05-14

02 32030-11-15

Product Main Page

01

McCarthy Tétrault

Ozanimod

CPHI Shenzhen

Not Confirmed

McCarthy Tétrault

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-05-14

Date Granted : 2017-03-14

Brand Name : ZEPOSIA

Patent Number : 2723904

Filing Date : 2009-05-14

Strength per Unit : 0.92 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-05-14

Date Granted : 2017-03-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

McCarthy Tétrault

Ozanimod

CPHI Shenzhen

Not Confirmed

McCarthy Tétrault

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-05-14

Date Granted : 2017-03-14

Brand Name : ZEPOSIA

Patent Number : 2723904

Filing Date : 2009-05-14

Strength per Unit : 0.23 mg / 0.46 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-05-14

Date Granted : 2017-03-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

McCarthy Tétrault

Ozanimod

CPHI Shenzhen

Not Confirmed

McCarthy Tétrault

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-05-14

Date Granted : 2017-03-14

Brand Name : ZEPOSIA

Patent Number : 2723904

Filing Date : 2009-05-14

Strength per Unit : 0.23 mg / 0.46 mg

Dosage Form : KIT

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-05-14

Date Granted : 2017-03-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

McCarthy Tétrault

Ozanimod

CPHI Shenzhen

Not Confirmed

McCarthy Tétrault

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-15

Date Granted : 2018-01-16

Brand Name : ZEPOSIA

Patent Number : 2780772

Filing Date : 2010-11-15

Strength per Unit : 0.92 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-11-15

Date Granted : 2018-01-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

McCarthy Tétrault

Ozanimod

CPHI Shenzhen

Not Confirmed

McCarthy Tétrault

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-15

Date Granted : 2018-01-16

Brand Name : ZEPOSIA

Patent Number : 2780772

Filing Date : 2010-11-15

Strength per Unit : 0.23 mg / 0.46 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-11-15

Date Granted : 2018-01-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

McCarthy Tétrault

Ozanimod

CPHI Shenzhen

Not Confirmed

McCarthy Tétrault

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-15

Date Granted : 2018-01-16

Brand Name : ZEPOSIA

Patent Number : 2780772

Filing Date : 2010-11-15

Strength per Unit : 0.23 mg / 0.46 mg

Dosage Form : KIT

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-11-15

Date Granted : 2018-01-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!